Toshio Abe Selected Research

Neurogenic Inflammation

9/2005	Endogenous cannabinoid receptor agonists inhibit neurogenic inflammations in guinea pig airways.
5/2005	The cannabinoid receptor agonist WIN 55212-2 inhibits neurogenic inflammations in airway tissues.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Toshio Abe Research Topics

Disease

5	Asthma (Bronchial Asthma) 10/2017 - 06/2006
2	Neurogenic Inflammation 09/2005 - 05/2005
1	Venous Thromboembolism 01/2019
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2019
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 01/2019
1	Autoimmune Diseases (Autoimmune Disease) 01/2019
1	Nasal Obstruction 10/2017
1	Seasonal Allergic Rhinitis (Hay Fever) 10/2017
1	Allergic Rhinitis 10/2017
1	Common Cold 09/2012
1	Inflammation (Inflammations) 01/2010
1	Respiratory Sounds (Crackle) 08/2009
1	Food Hypersensitivity (Food Allergy) 08/2009
1	Atopic Dermatitis (Atopic Eczema) 08/2009
1	Tuberculosis (Tuberculoses) 10/2008
1	Pathologic Constriction (Stenosis) 10/2008
1	Hypertension (High Blood Pressure) 01/2007
1	Insulin Resistance 01/2007
1	Obesity 01/2007
1	Type 2 Diabetes Mellitus (MODY) 01/2007
1	Diabetes Complications 01/2007
1	Hyperlipidemias (Hyperlipidemia) 01/2007
1	Carcinoma (Carcinomatosis) 12/2002
1	Coronary Vasospasm (Coronary Artery Vasospasm) 12/2002
1	Neoplasms (Cancer) 12/2002

Drug/Important Bio-Agent (IBA)

3	Cannabinoid Receptor AgonistsIBA 01/2010 - 05/2005
2	Leukotriene Antagonists (Leukotriene Receptor Antagonists)IBA 10/2017 - 09/2012
2	(3R)- ((2,3- dihydro- 5- methyl- 3- ((4- morpholinyl)methyl)pyrrolo- (1,2,3- de)- 1,4- benzoxazin- 6- yl)(1- naphthalenyl))methanone (WIN 55,212)IBA 01/2010 - 05/2005
2	tulobuterolIBA 01/2010 - 06/2006
1	Antiphospholipid AntibodiesIBA 01/2019
1	RivaroxabanIBA 01/2019
1	SteroidsIBA 10/2017
1	pranlukastIBA 10/2017
1	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2012
1	CannabinoidsIBA 01/2010
1	AntigensIBA 01/2010
1	Bronchodilator Agents (Bronchodilators)IBA 01/2010
1	Pharmaceutical PreparationsIBA 01/2010
1	CB2 Cannabinoid ReceptorIBA 01/2010
1	Ketotifen (Ketotifene)FDA Link 08/2009
1	suplatast tosilateIBA 08/2009
1	Histamine (Histamine Dihydrochloride)FDA Link 08/2009
1	CytokinesIBA 08/2009
1	G-protein beta3 subunitIBA 01/2007
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 12/2002

Therapy/Procedure

2	Therapeutics 01/2019 - 01/2007
1	Stents 10/2008
1	X-Ray Film 10/2008
1	Intra-Aortic Balloon Pumping 12/2002
1	Cardiopulmonary Bypass (Heart-Lung Bypass) 12/2002